Committees:
- Environmental, Social and Governance
- Human Resources and Compensation
Attributes and Skills Provided to the Board:
- Executive Leadership in Life Sciences/Healthcare
- Public Company Executive Experience
- Global Business Experience
- Operational Experience
- Growth Strategy and Market Expansion
- M&A and Integration Experience
Expertise Provided to the Board:
Tina S. Nova is an industry veteran in life sciences, with deep experience in building and leading successful life science businesses from conception through IPO, including public-company CEO experience. She has deep insights into commercial operations, sales and marketing efforts, as well as extensive experience in the creation of start-up companies and the commercialization of products with a focus on molecular diagnostics. Ms. Nova brings significant experience in mergers, acquisitions and integration, having overseen the sale of several companies as both an executive and director that created value for shareholders. She also provides relevant life sciences executive leadership experience, having held Chief Executive roles at Decipher Biosciences, until its $600 million sale to Veracyte (NASDAQ: VCYT) in 2021, Molecular Stethoscope and Genoptix, which she spent 15 years as the co-founder and oversaw its $470 million sale to Novartis AG (NYSE: NVS) in 2011.